← back to search

Jinli Wang

Sun Yat-sen University · CN
Area of research
Immunology · Epidemiology
Research interest
Research interests include Autophagy in Disease and Therapy, Immune Cell Function and Interaction, T-cell and B-cell Immunology, and Extracellular vesicles in disease.
h-index
22
citations
1,713
works
97
NIH funding
primary concept
email

Recent publications

Cross-feeding and co-degradation within a bacterial consortium dominated by challenging-to-culture <i>Leucobacter</i> sp. HA-1 enhances sulfonamide degradation
Applied and Environmental Microbiology 2025cited by 3position: middledoi
A ’Stealth’ gene delivery system targeting hepatic stellate cells for the treatment of liver fibrosis
International Journal of Pharmaceutics 2025cited by 2position: middledoi
TCM formula for trauma treatment screening and its role of promoting infectious wound coalescence investigating
Research in Veterinary Science 2024cited by 4position: middledoi
Mesenchymal stem cell-derived exosomal microRNA-367–3p alleviates experimental autoimmune encephalomyelitis via inhibition of microglial ferroptosis by targeting EZH2
Biomedicine & Pharmacotherapy 2023cited by 64position: middledoi
iTRAQ-based comparative proteomics reveal an enhancing role of PRDX6 in the freezability of Mediterranean buffalo sperm
BMC Genomics 2023cited by 7position: middledoi
A functional polymorphism of microRNA-143 is associated with the risk of type 2 diabetes mellitus in the northern Chinese Han population
Frontiers in Endocrinology 2022cited by 4position: middledoi
NAD+ improved experimental autoimmune encephalomyelitis by regulating SIRT1 to inhibit PI3K/Akt/mTOR signaling pathway
Aging 2021cited by 18position: firstdoi
NAD+ Improved Experimental Autoimmune Encephalomyelitis by Regulating SIRT1 to Inhibit PI3K/ Akt /mTOR Signaling Pathway
Research Square 2021cited by 0position: firstdoi
Non-small cell lung cancer-targeted, redox-sensitive lipid-polymer hybrid nanoparticles for the delivery of a second-generation irreversible epidermal growth factor inhibitor—Afatinib: In vitro and in vivo evaluation
Biomedicine & Pharmacotherapy 2019cited by 49position: firstdoi
One-step synthesis and luminescence properties of tetragonal double tungstates nanocrystals
Nanoscale 2016cited by 18position: middledoi
Elevated circulating CD14lowCD16+ monocyte subset in primary biliary cirrhosis correlates with liver injury and promotes Th1 polarization
Clinical and Experimental Medicine 2015cited by 37position: middledoi
MicroRNA-155 Promotes Autophagy to Eliminate Intracellular Mycobacteria by Targeting Rheb
PLoS Pathogens 2013cited by 254position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Li Guo · Capital Medical University2 papers (2021–2021)Xueqin Song · Hebei Medical University2 papers (2021–2021)Pengtao Sun · Guangzhou University of Chinese Medicine2 papers (2021–2021)Guo-Jun Tan · Hebei Medical University2 papers (2021–2021)Zijun Wang · Jiangxi University of Traditional Chinese Medicine1 papers (2016–2016)Xiangping Li · Guangxi University1 papers (2023–2023)Rong Zhao · Guangzhou University of Chinese Medicine1 papers (2015–2015)Duan Ya · Hebei General Hospital1 papers (2022–2022)Jiuping Zhong · Sun Yat-sen University1 papers (2016–2016)Lin Zhou · Jinan University1 papers (2013–2013)Yi Wu · Nanjing Agricultural University1 papers (2024–2024)Bohua Chen · Nantong University1 papers (2019–2019)Qiu Zhong · Nanjing Agricultural University1 papers (2013–2013)Xiaomin Lai · Fujian Medical University1 papers (2013–2013)Shuang Wang · Shandong University1 papers (2019–2019)Kai Ding · Nantong University1 papers (2025–2025)Xin-Yi Tian · Nanjing University of Chinese Medicine1 papers (2023–2023)Xiaoqin Yin · Nantong University1 papers (2019–2019)Peifeng Ke · Guangzhou University of Chinese Medicine1 papers (2015–2015)Jiaguo Liu · Shandong University1 papers (2024–2024)